Interleukin-6 enhances expression of adenosine A1 receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices

Neuropsychopharmacology

Volumn 24, Issue 1, 2001, Pages 86-96

  Biber, Knut ^a,b   Lubrich, Beate ^a   Fiebich, Bernd L ^a   Boddeke, Hendrikus W G M ^b   Van Calker, Dietrich ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Adenosine A1 receptor; Astrocytes; Interleukin 6; Neuroprotection; Organotypic brain slices

Indexed keywords

ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2B RECEPTOR; CARBAMAZEPINE; INTERLEUKIN 6; MESSENGER RNA; PHOSPHATIDYLINOSITIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN SLICE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ELECTROCONVULSIVE THERAPY; NEUROPROTECTION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SLEEP DEPRIVATION;

ADENOSINE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-6; NEURONS; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLINOSITOLS; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 0035212170     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(00)00169-X     Document Type: Article

References (68)

1. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases
2. Upregulation of A1 adenosine receptors in human temporal lobe epilepsy: A quantitative autoradiographic study
3. Neurotrophins and depression
4. Cloning and sequencing of mouse ribosomal protein S12 cDNA
5. Carbamazepine inhibits the potentiation by adenosine analogues of agonist induced inositolphophosphate formation in hippocampal astrocyte cultures
6. Adenosine A1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression
7. 1-receptors in astrocyte cultures affects coupling to the phosphoinositol signaling pathway
8. Transgenic mice and cytokine actions in the brain: Bridging the gap between structural and functional neuropathology
9. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
10. Activation of A1 adenosine or mGLU3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100β protein from cultured astrocytes
11. 1 binding sites
12. Upregulation of adenosine A1-receptors and forskolin binding sites following chronic treatment with caffeine or carbamazepine
13. Adenosine - An endogenous neuroprotective metabolite and neuromodulator
14. A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates
15. Purinergic mechanisms in epilepsy
16. A molecular and cellular theory of depression
17. Protective effect of adenosine and a novel xanthine derivative propentofylline on the cell damage after bilateral carotid occlusion in the gerbil hippocampus
18. Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells
19. VI. Nomenclature and classification of purinoceptors
20. Formation of layer-specific fiber projection to the hippocampus in vitro
21. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia
22. Interleukin-6 (IL-6): A molecule with both beneficial and destructive potentials
23. Organotypic slice cultures: A technique has come of age
24. Rapid synthesis of DNA deletion constructs for mRNA quantification: Analysis of astrocyte mRNA
25. 2 receptors, adenylate cyclase, and the adenosine uptake site
26. Physiological and pathological roles of interleukin-6 in the central nervous system
27. Enhanced expression of interleukin (IL)-1 and IL-6 messenger RNA and bioactive protein after hypoxia-ischemia in neonatal rats
28. Cyclopentyladenosine-induced homologous down-regulation of A1 adenosine receptors (A1AR) in intact neurones is accompanied by receptor sequestration but not a reduction in A1AR mRNA expression or G protein alpha-subunit content
29. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning
30. Extracellular adenosine levels in neostriatum and hippocampus during rest and activity periods of rats
31. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurones in a chemically defined medium from fetal and postnatal rat midbrains
32. Interleukin-6 and leukemia inhibitory factor promote the survival of acetylcholinesterase-positive neurones in culture from embryonic rat spinal cord
33. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat
34. Hypoxia/reoxygenation-mediated induction of astrocyte interleukin 6: A paracrine mechanism potentially enhancing neurone survival
35. Sympathetic neurones can produce and respond to interleukin-6
36. Cloning and expression of an A1 adenosine receptor from rat brain
37. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: A role for neurotrophic and neuroprotective effects in manic depressive illness
38. Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils
39. Interactions of the nervous and immune system in development, normal brain homeostasis, and disease
40. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system
41. Macrophage colony-stimulating factor augments beta-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells
42. Adenosine and the concept of 'retaliatory metabolites'
43. 2 adenosine systems in the brain
44. Adenosine receptor subtypes: Characterization and therapeutic regulation
45. Effect of pentylentetrazol-induced seizures on A1 adenosine receptor regional density in the mouse brain: A quantitative autoradiographic study
46. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice
47. European stroke prevention study-2 results: Serendipitous demonstration of neuroprotection induced by adenosine accumulation?
48. Adenosine in sleep and wakefulness
49. Adenosine: A mediator of the sleep-inducing effects of prolonged wakefulness
50. Receptors for purines and pyrimidines
51. Purinergic inhibition of neurotransmitter release in the central nervous system
52. Neuroprotective role of adenosine in cerebral ischemia
53. Adenosine and brain ischemia
54. Desensitization and internalization of adenosine A1 receptors in rat brain by in vivo treatment with R-PIA: Involvement of coated vesicles
55. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid
56. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain
57. Protective mechanism of adenosine in neurones and glial cells
58. Stimulation of interleukin-6 secretion and gene transcription in primary astrocytes by adenosine
59. The effects of caffeine on ischemic neuronal injury as determined by magnetic resonance imaging and histopathology
60. Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurones
61. Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells
62. Adenosine regulates via two different types of receptors the accumulation of cyclic AMP in cultured brain cells
63. Carbamazepine distinguishes between adenosine receptor subtypes that mediate, respectively, regulation of cyclic AMP formation and inhibition of inositolphosphate formation
64. Interleukin-6 protects cultured rat hippocampal neurones against glutamate-induced cell death
65. 1 receptors